A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma

The purpose of this study was to compare the response rate, overall and 1-year survival in patients with advanced melanoma treated with a standard therapy, dacarbazine and interferon-alpha (DTIC/IFN), or combination chemotherapy, consisting of dacarbazine, BCNU, cisplatin and tamoxifen (DBCT). Treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Middleton, M R, Lorigan, P, Owen, J, Ashcroft, L, Lee, S M, Harper, P, Thatcher, N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363341/
https://www.ncbi.nlm.nih.gov/pubmed/10735499
http://dx.doi.org/10.1054/bjoc.1999.1056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363341/
https://www.ncbi.nlm.nih.gov/pubmed/10735499
http://dx.doi.org/10.1054/bjoc.1999.1056

Ejemplares similares